BackEnanta Pharmaceuticals Overview
Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Target Price

Where could ENTA trade next? Consensus target price: $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.96

Average Target Price

$20.0054.3% upside

1 analysts in the last 4 months

High: $20 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-23H.C. WainwrightBrandon Folkes$2054.3% upsideOpen
2025-10-01JefferiesAkash Tewari$2054.3% upsideOpen
2025-06-03JMP SecuritiesRoy Buchanan$2485.2% upsideOpen
2022-12-09H.C. Wainwright$56332.1% upsideOpen
2022-11-22RBC Capital$54316.7% upsideOpen
2022-07-29Piper SandlerYasmeen Rahimi$87571.3% upsideOpen

Enanta Pharmaceuticals (ENTA) FAQ

As of the most recent data, ENTA shows a target price of $20. Scroll down for historical charts and peer comparison views.

If Enanta Pharmaceuticals moved to the average analyst target of $20, shares would be roughly 54.3% higher than $12.96. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Enanta Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has Enanta Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $20) with ownership activity and broader fundamentals.

Enanta Pharmaceuticals's target price is $20; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.